Cytosorbents
CTSO
#9856
Rank
C$57.6 M
Marketcap
C$0.92
Share price
-1.47%
Change (1 day)
-29.24%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -C$18.2 Million

According to Cytosorbents's latest financial reports the company's current earnings are C$36.97 Million. In 2024 the company made an earning of -C$31.12 Million, an increase over its 2023 earnings that were of -C$40.14 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$18.2 Million-41.53%
2024 -C$31.12 Million-22.49%
2023 -C$40.14 Million-13.52%
2022 -C$46.42 Million34.04%
2021 -C$34.63 Million182.17%
2020 -C$12.28 Million-55.97%
2019 -C$27.87 Million14.17%
2018 -C$24.41 Million95.14%
2017 -C$12.51 Million-22.32%
2016 -C$16.11 Million39.1%
2015 -C$11.58 Million-12.89%
2014 -C$13.29 Million89%
2013 -C$7.04 Million26.65%
2012 -C$5.56 Million-26.02%
2011 -C$7.51 Million-288.45%
2010 C$3.98 M-4.17%
2009 C$4.15 M-287.19%
2008 -C$2.22 Million-47.12%
2007 -C$4.2 Million41.78%
2006 -C$2.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Meridian Bioscience
VIVO
C$75.98 M-537.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
C$1.09 B-6,397.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
C$4.47 B-25,894.75%๐Ÿ‡บ๐Ÿ‡ธ USA